risperidone has been researched along with Hypomania in 10 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This is a double-blind, placebo-controlled, parallel-grouped clinical trial, which was designed to investigate the potential effects of melatonin add-on treatment with lithium and risperidone on acute manic episodes in patients with bipolar disorder (BD)." | 5.34 | Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial. ( Akhondzadeh, S; Bahmani, S; Bayanati, S; Mahdavinasa, M; Moghaddam, HS; Rezaei, F, 2020) |
| " The decision was made to restart corticosteroid treatment for the patient's primary adrenal insufficiency (formerly known as Addison disease), coupled with administration of both risperidone and valproate for mania and psychosis." | 4.31 | Acute Mania in a Patient With Primary Adrenal Insufficiency Due to Autoimmune Adrenalitis: A Case Report. ( Brown, NJ; Farokhpay, R; Fote, G; Gabriel, C; Luo, J; Wang, A, 2023) |
| "Patients in the acute phase of mania were assigned into two parallel groups given either lithium (blood level of 0." | 3.11 | Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial. ( Abedini, T; Akhondzadeh, S; Ardakani, MK; Ghannadi, F; Hosseyni, R; Moghaddam, HS; Talaei, A, 2022) |
| "Mania (or manic episodes) is a common symptom of bipolar disorder and is frequently accompanied by hyperactivity and delusions; given the cost and resources available, there is a paucity of evidence for direct comparison of different drugs." | 2.82 | A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years. ( Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J, 2022) |
| "Chronic risperidone did not reverse mania-like behavior in DAT knockdown mice." | 1.62 | Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice. ( Arnt, J; Bundgaard, C; Cope, ZA; Geyer, MA; Kenton, JA; Martin, MV; Minassian, A; Perry, W; van Enkhuizen, J; Young, JW, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishi, T | 2 |
| Ikuta, T | 1 |
| Matsuda, Y | 1 |
| Sakuma, K | 1 |
| Okuya, M | 1 |
| Nomura, I | 1 |
| Hatano, M | 1 |
| Iwata, N | 2 |
| Wozniak, J | 1 |
| DiSalvo, M | 1 |
| Farrell, A | 1 |
| Yule, A | 1 |
| Joshi, G | 1 |
| Cook, E | 1 |
| Faraone, SV | 1 |
| Biederman, J | 1 |
| Abedini, T | 1 |
| Hosseyni, R | 1 |
| Ghannadi, F | 1 |
| Moghaddam, HS | 2 |
| Ardakani, MK | 1 |
| Talaei, A | 1 |
| Akhondzadeh, S | 2 |
| Ikeda, M | 1 |
| Saito, T | 1 |
| Kanazawa, T | 1 |
| Hong, Y | 1 |
| Huang, W | 1 |
| Cao, D | 1 |
| Xu, J | 1 |
| Wei, H | 1 |
| Zhang, J | 1 |
| Wang, L | 1 |
| Yu, CL | 1 |
| Carvalho, AF | 1 |
| Thompson, T | 1 |
| Tsai, TC | 1 |
| Tseng, PT | 1 |
| Hsu, CW | 1 |
| Hsu, TW | 1 |
| Liang, CS | 1 |
| Brown, NJ | 1 |
| Wang, A | 1 |
| Fote, G | 1 |
| Gabriel, C | 1 |
| Farokhpay, R | 1 |
| Luo, J | 1 |
| Bahmani, S | 1 |
| Bayanati, S | 1 |
| Mahdavinasa, M | 1 |
| Rezaei, F | 1 |
| Cope, ZA | 1 |
| Kenton, JA | 1 |
| Minassian, A | 1 |
| Martin, MV | 1 |
| Perry, W | 1 |
| Bundgaard, C | 1 |
| Arnt, J | 1 |
| van Enkhuizen, J | 1 |
| Geyer, MA | 1 |
| Young, JW | 1 |
| Naguy, A | 1 |
3 reviews available for risperidone and Hypomania
| Article | Year |
|---|---|
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzo | 2022 |
Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Haloperidol; Humans; Mania; Olanzapine; Quetia | 2023 |
2 trials available for risperidone and Hypomania
| Article | Year |
|---|---|
Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial.
Topics: Amides; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Double-Bli | 2022 |
Efficacy of melatonin as an adjunct in the treatment of acute mania: a double-blind and placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; H | 2020 |
5 other studies available for risperidone and Hypomania
| Article | Year |
|---|---|
Can pediatric bipolar disorder be successfully treated when comorbid with conduct disorder? A secondary analysis of clinical trials of risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole.
Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; | 2022 |
Proportion of subjects with psychotic features in bipolar disorder correlated with treatment response by antipsychotics for acute mania.
Topics: Antipsychotic Agents; Bipolar Disorder; Humans; Mania; Olanzapine; Psychotic Disorders; Risperidone | 2022 |
Acute Mania in a Patient With Primary Adrenal Insufficiency Due to Autoimmune Adrenalitis: A Case Report.
Topics: Addison Disease; Adrenal Cortex Hormones; Adrenal Insufficiency; Adult; Humans; Male; Mania; Risperi | 2023 |
Chronic antipsychotic treatment exerts limited effects on the mania-like behavior of dopamine transporter knockdown mice.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Bipolar Disorder; Dibenzocycloheptenes; Disease Mod | 2021 |
Typical versus Atypical Antipsychotics for Acute Mania: Psychopharmacological Considerations.
Topics: Antipsychotic Agents; Humans; Mania; Olanzapine; Risperidone | 2022 |